Untreated Adult Acute Myeloid Leukemia Completed Phase 1 Trials for Daunorubicin (DB00694)

IndicationStatusPhase
DBCOND0028532 (Untreated Adult Acute Myeloid Leukemia)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00039117Oblimersen, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid LeukemiaTreatment